A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial

被引：8
|
作者：
Bosaeed, Mohammad [1 ,2 ,3 ]
Mahmoud, Ebrahim [1 ]
Hussein, Mohammad [3 ]
Alharbi, Ahmad [1 ]
Alsaedy, Abdulrahman [1 ,2 ]
Alothman, Adel [1 ,2 ]
Aljeraisy, Majed [3 ,4 ]
Alqahtani, Hajar [4 ]
Nashabat, Marwan [3 ]
Almutairi, Badriah [3 ]
Almaghaslah, Manar [1 ]
Aldibasi, Omar [3 ]
AlJohani, Sameera [2 ,3 ]
Bouchama, Abderrezak [3 ,5 ]
Arabi, Yaseen [2 ,5 ]
Alaskar, Ahmad [2 ,3 ]
机构：
[1] King Abdul Aziz Med City, Dept Med, Riyadh, Saudi Arabia
[2] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia
[3] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
[4] King Abdul Aziz Med City, Pharmaceut Care Dept, Riyadh, Saudi Arabia
[5] King Abdul Aziz Med City, Intens Care Dept, Riyadh, Saudi Arabia
来源：
TRIALS | 2020年 / 21卷 / 01期
关键词：
COVID-19; Randomised controlled trial; protocol; Favipiravir; Hydroxychloroquine; Saudi Arabia;
D O I：
10.1186/s13063-020-04825-x
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial
    Brown, Li-An K.
    Freemantle, Nick
    Breuer, Judy
    Dehbi, Hakim-Moulay
    Chowdhury, Kashfia
    Jones, Gemma
    Ikeji, Felicia
    Ndoutoumou, Amalia
    Santhirakumar, Krishneya
    Longley, Nicky
    Checkley, Anna M.
    Standing, Joseph F.
    Lowe, David M.
    TRIALS, 2021, 22 (01)
  • [32] Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
    Carmel M. McEniery
    Marie Fisk
    Karen Miles
    Fotini Kaloyirou
    Annette Hubsch
    Jane Smith
    Ian B. Wilkinson
    Joseph Cheriyan
    Trials, 21
  • [33] Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection-a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
    Panda, Prasan Kumar
    Bandyopadhyay, Arkapal
    Singh, Budha Charan
    Moirangthem, Bikram
    Chikara, Gaurav
    Saha, Sarama
    Bahurupi, Yogesh Arvind
    TRIALS, 2020, 21 (01)
  • [34] Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
    Rosario Garcia-Vicuña
    Francisco Abad-Santos
    Isidoro González-Alvaro
    Francisco Ramos-Lima
    Jesús Sanz Sanz
    Trials, 21
  • [35] Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
    Garcia-Vicuna, Rosario
    Abad-Santos, Francisco
    Gonzalez-Alvaro, Isidoro
    Ramos-Lima, Francisco
    Sanz, Jesus Sanz
    TRIALS, 2020, 21 (01)
  • [36] Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
    Dushianthan, Ahilanandan
    Clark, Howard
    Madsen, Jens
    Mogg, Robin
    Matthews, Lewis
    Berry, Lee
    de la Serna, Jorge Bernardino
    Batchelor, Jame
    Brealey, David
    Hussell, Tracy
    Porter, Joanna
    Djukanovic, Ratko
    Feelisch, Martin
    Postle, Anthony
    Grocott, Michael P. W.
    TRIALS, 2020, 21 (01)
  • [37] Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
    Ahilanandan Dushianthan
    Howard Clark
    Jens Madsen
    Robin Mogg
    Lewis Matthews
    Lee Berry
    Jorge Bernardino de la Serna
    James Batchelor
    David Brealey
    Tracy Hussell
    Joanna Porter
    Ratko Djukanovic
    Martin Feelisch
    Anthony Postle
    Michael P. W. Grocott
    Trials, 21
  • [38] Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
    Hany M. Dabbous
    Manal H. El‑Sayed
    Gihan El Assal
    Hesham Elghazaly
    Fatma F. S. Ebeid
    Ahmed F. Sherief
    Maha Elgaafary
    Ehab Fawzy
    Sahar M. Hassany
    Ahmed R. Riad
    Mohamed A. TagelDin
    Scientific Reports, 11
  • [39] The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Fatemeh Sadat Hosseini
    Alireza Malektojari
    Sara Ghazizadeh
    Mehdi Hassaniazad
    Parivash Davoodian
    Habib Dadvand
    Amin Reza Nikpoor
    Sara Nikoofal-Sahlabadi
    Sara Kahoori
    Mojtaba Sepandi
    Soheil Hassanipour
    Mohammad Fathalipour
    Trials, 22
  • [40] Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial
    Stoll, Felicitas
    Blank, Antje
    Mikus, Gerd
    Czock, David
    Foerster, Kathrin I.
    Hermann, Simon
    Haeussler, Katja
    Muhareb, Amin
    Hummler, Simone
    Weiss, Johanna
    Burhenne, Juergen
    Haefeli, Walter E.
    TRIALS, 2020, 21 (01)
12345